This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global flow cytometry market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the flow cytometry market. The secondary sources used for this study include the World Health Organization (WHO), the Organization for Economic Co-operation and Development (OECD), the Global Cancer Observatory (GLOBOCAN), the World Bank, Eurostat, the Joint United Nations Programme on HIV/AIDS (UNAIDS), the National Institutes of Health (NIH), Institute for Health Metrics and Evaluation (US), International Society for Advancement of Cytometry (US), US FDA, Health Canada, EuroStemCell, German Cancer Research Center, NHS (UK), Cancer Research UK (UK), Stem Cell Foundation, French National Research Agency (France), Italian National Institute of Health, National Cancer Center Japan, Ministry of Science & Technology (India), Australasian Cytometry Society (Australia), the Cytometry Society (India), International Clinical Cytometry Society (US), and African Cancer Registry Network; Lens. Org. National Center for Biotechnology Information (NCBI), corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; research journals; press releases; and trade, business, professional associations, and among others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global flow cytometry market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as personnel from pharmaceutical and biopharmaceutical industries, CMOs and CROs, academic & research institutes, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were conducted across four major regions, including the Asia Pacific, North America, Europe, Latin America, and the Middle East & Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews. The following is a breakdown of the primary respondents:
Note: Tiers are defined based on a company’s total revenue. As of 2023, Tier 1 = >USD 1 Bn, Tier 2 = USD 500 Mn to USD 1 Bn, and Tier 3 <USD 500 Mn.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The global size of the market was estimated through multiple approaches. A detailed market estimation approach was followed to estimate and validate the value of the flow cytometry market and other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
-
The key players in the industry and market have been identified through extensive primary and secondary research.
-
The revenues generated from the flow cytometry business of leading players have been determined through primary and secondary research.
-
All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
Market Size Estimation Methodology-Bottom-up approach
To know about the assumptions considered for the study, Request for Free Sample Report
Top-down Approach-
Data Triangulation
After estimating the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Flow cytometry is a laser-based technology used to measure & analyze multiple physical characteristics of microscopic particles, including cells (mammalian, plant, algae, yeast, and bacteria); cellular matter (enzymes, proteins, nuclei, RNA, and DNA); and latex beads. Several properties related to cellular structure and functions, such as cell size, cell cycle, cell viability, enzymatic activities, membrane potentials, cellular antigens, DNA/RNA, protein synthesis, and surface receptors, can be analyzed with the help of flow cytometry. Flow cytometry has several applications in scientific research and clinical diagnosis.
Key Stakeholders
-
Flow cytometry equipment manufacturers, vendors, and distributors
-
Flow cytometry service providers
-
R&D companies
-
Academia, research institutes, and government organizations
-
Venture capitalists and other public-private funding agencies
-
Pharmaceutical, cosmeceutical, and biotechnology companies
-
Healthcare service providers (including hospitals and diagnostic centers)
-
Clinical research organizations (CROs)
-
Clinical testing laboratories and service providers
The main objectives of this study are as follows:
-
To define, describe, and forecast the global flow cytometry market based on the technology, product & service, application, end-user, and region
-
To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, and opportunities)
-
To strategically analyze micro markets with respect to individual growth trends, future prospects, and contributions to the overall cell analysis market
-
To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
-
To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East and Africa
-
To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies.
-
To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the flow cytometry market.
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:
Geographical Analysis
-
Further breakdown of the Rest of Europe's flow cytometry market, by country
-
Further breakdown of the Rest of the Asia Pacific flow cytometry market, by country
Company Information
-
Detailed analysis and profiling of additional market players (up to five)
Segment Analysis
-
Further breakdown of the application area segment as per the service portfolio of prominent players operating in the market.
-
Additional segmentation and market sizing for spectral flow cytometry vs conventional flow cytometry market.
Pattrick
Dec, 2022
What are the growth opportunities in the North American region for the global flow cytometry market?.
Ash
Sep, 2023
Hi Ash,
Here are some of the leading companies in the flow cytometry market:
1. Becton, Dickinson and Company (BD)
2. Danaher Corporation
3. Thermo Fisher Scientific, Inc.
4. Agilent Technologies, Inc.
5. Bio-Rad Laboratories, Inc.
6. Miltenyi Biotec
7. Sysmex Corporation
8. Stratedigm, Inc.
9. Apogee Flow Systems Ltd.
10. Sony Biotechnology, Inc.
These companies offer a wide range of flow cytometry products and services, including instruments, reagents, software, and consulting. They also play a leading role in the development of new flow cytometry technologies.
The flow cytometry market is expected to grow significantly in the next few years, due to a number of factors, including:
1. The increasing demand for personalized medicine
2. The rising incidence of chronic diseases
3. The development of new flow cytometry technologies
The companies listed above are well-positioned to benefit from the growth of the flow cytometry market. They have the resources, expertise, and track record to continue to innovate and lead the market in the years to come.
Here are some of the factors that are driving the growth of the flow cytometry market:
Increasing demand for personalized medicine: Flow cytometry is a powerful tool that can be used to study the behavior of individual cells. This information can be used to personalize treatments for diseases such as cancer.
Rising incidence of chronic diseases: The incidence of chronic diseases such as cancer, HIV, and autoimmune diseases is on the rise. Flow cytometry is a valuable tool for diagnosing and monitoring these diseases.
Development of new flow cytometry technologies: New flow cytometry technologies are being developed that offer increased sensitivity, resolution, and speed. These new technologies are opening up new applications for flow cytometry in areas such as drug discovery and clinical research..
Ash
Sep, 2023
list all the companies in flow cytometry market.
Louis
Mar, 2022
How much share, does the each segment holds, of the global Flow Cytometry Market?.
Mary
Mar, 2022
How the end user segment is benefited by the emerging innovations in the Global Flow Cytometry Market?.
Patricia
Mar, 2022
How the North American region is expected to dominate the Global Flow Cytometry Market?.